Martingale Asset Management L P Atreca, Inc. Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$7.82 - $13.8 $112,709 - $198,899	-14,413 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$13.0 - $19.34 $2,600 - $3,868	200 Added 1.41%	14,413 $220,000
Q4 2020 Feb 10, 2021	SELL	$13.03 - $17.09 $607,198 - $796,394	-46,600 Reduced 76.63%	14,213 $229,000
Q3 2020 Nov 12, 2020	BUY	$12.67 - $23.19 $770,500 - $1.41 Million	60,813 New	60,813 $849,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.